Literature DB >> 9094623

p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis.

S K Chiou1, E White.   

Abstract

E1A expression during adenovirus infection induces apoptosis. E1A expression causes accumulation of the p53 tumor suppressor protein, and E1A-induced apoptosis is p53 mediated in primary rodent cells, implying that p53 induction may be linked to apoptosis induction by E1A. Adenoviruses containing mutations in the E1A gene were tested for the ability to trigger both p53 accumulation and the appearance of enhanced cytopathy (cyt phenotype) and degradation of DNA (deg phenotype), indicative of apoptosis in infected HeLa cells. The adenoviruses had mutations which disrupted the pRb- and/or p300-binding activities of E1A so that the relationship between p53 induction and apoptosis and binding to these cellular proteins by E1A could be determined. An E1A mutation that specifically disrupted the p300-binding activity failed to induce p53 accumulation, whereas mutations in E1A which affected pRb binding induced p53 accumulation. Thus, p300 binding was required and pRb binding was dispensable for E1A-mediated accumulation of p53 in HeLa cells. All the E1A mutant viruses, regardless of the ability to induce p53 accumulation, induced the cyt and deg phenotypes, suggesting that p53 induction in infected HeLa cells was not essential for apoptosis, nor was binding of E1A to the pRb and/or p300 protein. The possibility that E1A induced a p53-independent apoptosis pathway was tested by analyzing the appearance of the cyt and deg phenotypes in Saos-2 cells, which were null for both alleles of p53, upon adenovirus infection. An adenovirus expressing wild-type 12S E1A induced both the cyt and deg phenotypes in Saos-2 cells, as did all the E1A mutant viruses. Thus, E1A expression during infection of human cells may trigger redundant p53-independent and -dependent apoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094623      PMCID: PMC191498     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  Adenovirus promoters and E1A transactivation.

Authors:  A J Berk
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

2.  Expression of adenovirus E1B mutant phenotypes is dependent on the host cell and on synthesis of E1A proteins.

Authors:  E White; B Stillman
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

3.  Regulation of adenovirus gene expression in human WI38 cells by an E1B-encoded tumor antigen.

Authors:  E White; B Faha; B Stillman
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

4.  Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells.

Authors:  P Sarnow; Y S Ho; J Williams; A J Levine
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

5.  Resolving the functions of overlapping viral genes by site-specific mutagenesis at a mRNA splice site.

Authors:  C Montell; E F Fisher; M H Caruthers; A J Berk
Journal:  Nature       Date:  1982-02-04       Impact factor: 49.962

6.  Nuclear envelope localization of an adenovirus tumor antigen maintains the integrity of cellular DNA.

Authors:  E White; S H Blose; B W Stillman
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

7.  Transformation-defective mutant of adenovirus type 5 containing a single altered E1a mRNA species.

Authors:  L R Carlock; N C Jones
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

8.  The retinoblastoma protein is phosphorylated during specific phases of the cell cycle.

Authors:  K Buchkovich; L A Duffy; E Harlow
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

9.  Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein.

Authors:  E White; R Cipriani
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

10.  Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA.

Authors:  E White; T Grodzicker; B W Stillman
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

View more
  31 in total

1.  p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.

Authors:  J N Harada; A J Berk
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Suppression of E1A-mediated transformation by the p50E4F transcription factor.

Authors:  E R Fernandes; R J Rooney
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  Induction of p53-independent apoptosis by the adenovirus E4orf4 protein requires binding to the Balpha subunit of protein phosphatase 2A.

Authors:  R C Marcellus; H Chan; D Paquette; S Thirlwell; D Boivin; P E Branton
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Inactivation of p21 by E1A leads to the induction of apoptosis in DNA-damaged cells.

Authors:  D Chattopadhyay; M K Ghosh; A Mal; M L Harter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex.

Authors:  E Querido; P Blanchette; Q Yan; T Kamura; M Morrison; D Boivin; W G Kaelin; R C Conaway; J W Conaway; P E Branton
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

6.  Bak and Bax function to limit adenovirus replication through apoptosis induction.

Authors:  Andrea Cuconati; Kurt Degenhardt; Ramya Sundararajan; Alan Anschel; Eileen White
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Regulation of the 26S proteasome by adenovirus E1A.

Authors:  A S Turnell; R J Grand; C Gorbea; X Zhang; W Wang; J S Mymryk; P H Gallimore
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

8.  Evidence that replication of the antitumor adenovirus ONYX-015 is not controlled by the p53 and p14(ARF) tumor suppressor genes.

Authors:  Sara J Edwards; Brett R Dix; Colleen J Myers; Deirdre Dobson-Le; Lily Huschtscha; Merilyn Hibma; Janice Royds; Antony W Braithwaite
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

9.  The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity.

Authors:  Chi Ying Cheng; Timra Gilson; Frédéric Dallaire; Gary Ketner; Philip E Branton; Paola Blanchette
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

10.  Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins.

Authors:  A V Samuelson; S W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.